Wonderboo (WONDR) Q2 2026 earnings summary

Executive summary

• Focused on expanding sales channels, including a new reseller agreement with MEDS Apotek, and addressing temporary product shortages that impacted sales.

• Completed a rights issue, strengthening the balance sheet and demonstrating continued shareholder support.

• Sales in the company’s own webshop remained stable but low, with emphasis shifting to reseller channels.

Financial highlights

• Net sales for Q2 2026 were 112 KSEK, down from 249 KSEK year-over-year.

• Operating loss for Q2 2026 was -1,138 KSEK, compared to -714 KSEK in Q2 2025.

• Net loss for Q2 2026 was -1,138 KSEK, versus -714 KSEK in Q2 2025.

• Cash and cash equivalents at period end were 68 KSEK, up from 50 KSEK year-over-year.

• Equity at period end was 151 KSEK, down from 1,039 KSEK year-over-year.

Outlook and guidance

• Management sees significant opportunities ahead, with a focus on leveraging product strengths and expanding distribution.

• Financial position remains strained; ongoing review of financing options is underway to ensure continued operations.